Schroder Investment Management Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.4M Buy
149,689
+123,450
+470% +$8.6M 0.01% 682
2025
Q4
$1.74M Sell
26,239
-123,367
-82% -$7.98M ﹤0.01% 905
2025
Q3
$10.1M Buy
149,606
+109,675
+275% +$8.68M 0.01% 662
2025
Q2
$3.49M Sell
39,931
-2,152
-5% -$169K ﹤0.01% 832
2025
Q1
$2.85M Sell
42,083
-7,335
-15% -$599K ﹤0.01% 858
2024
Q4
$3.85M Sell
49,418
-86,092
-64% -$6.37M ﹤0.01% 820
2024
Q3
$9.12M Sell
135,510
-117,094
-46% -$9.62M 0.01% 678
2024
Q2
$28.6M Buy
252,604
+44,435
+21% +$5.62M 0.03% 396
2024
Q1
$28.9M Buy
208,169
+25,529
+14% +$3.21M 0.03% 410
2023
Q4
$22.7M Sell
182,640
-1,034,562
-85% -$106M 0.03% 448
2023
Q3
$114M Sell
1,217,202
-29,394
-2% -$3.31M 0.17% 120
2023
Q2
$160M Sell
1,246,596
-338,482
-21% -$40.9M 0.23% 83
2023
Q1
$184M Buy
1,585,078
+25,557
+2% +$2.86M 0.27% 79
2022
Q4
$177M Sell
1,559,521
-88,037
-5% -$9.67M 0.28% 81
2022
Q3
$133M Buy
1,647,558
+120,534
+8% +$10.2M 0.22% 97
2022
Q2
$114M Buy
1,527,024
+87,948
+6% +$8.03M 0.17% 129
2022
Q1
$187M Buy
1,439,076
+91,892
+7% +$10.1M 0.25% 94
2021
Q4
$181M Buy
1,347,184
+218,120
+19% +$31.3M 0.24% 91
2021
Q3
$154M Sell
1,129,064
-40,288
-3% -$5.08M 0.24% 90
2021
Q2
$125M Buy
1,169,352
+470,124
+67% +$45.1M 0.16% 128
2021
Q1
$62.8M Buy
699,228
+203,692
+41% +$19.1M 0.08% 246
2020
Q4
$45.8M Buy
495,536
+267,260
+117% +$23.9M 0.06% 295
2020
Q3
$21.9M Buy
228,276
+132,664
+139% +$13.9M 0.04% 412
2020
Q2
$9.69M Buy
95,612
+20,984
+28% +$1.88M 0.02% 572
2020
Q1
$5.02M Buy
74,628
+70,956
+1,932% +$4.42M 0.01% 669
2019
Q4
$201K Buy
3,672
+1,412
+62% +$67K ﹤0.01% 1163
2019
Q3
$84K Buy
+2,260
New +$87.8K ﹤0.01% 1203
2018
Q2
Sell
-3,283,904
Closed -$60.9M 1282
2018
Q1
$60.9M Sell
3,283,904
-51,104
-2% -$756K 0.11% 249
2017
Q4
$47.8M Buy
+3,335,008
New +$43.3M 0.08% 297

Other funds holding DXCM

Schroder Investment Management Group's DXCM Position: Q1 2026 in Review

Schroder Investment Management Group increased its DexCom (DXCM) stake by 470% in Q1 2026, buying an estimated $8.6M and bringing the position to 149,689 shares worth $9.4M. The position accounts for 0.01% of the portfolio, ranked #682.

Schroder Investment Management Group first reported a position in DXCM in Q4 2017 and has held it in 29 quarters since. The position peaked at $187M in Q1 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Schroder Investment Management Group held 149,689 shares of DexCom worth $9.4M as of Q1 2026.
  • Schroder Investment Management Group bought 123,450 DexCom shares in Q1 2026, an estimated $8.6M.
  • DexCom made up 0.01% of Schroder Investment Management Group's portfolio in Q1 2026, its #682 holding.
  • Schroder Investment Management Group first reported a position in DexCom in Q4 2017 and has held it in 29 quarters since.
  • Schroder Investment Management Group's DexCom position peaked at $187M in Q1 2022.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.